Personalized Medicine – News and Features

A genomic tug of war for a gene activator could explain why some cancers respond to decitabine and others don't respond or become resistant over time.

Traditional bone marrow aspirate (BMA) stem cell extraction methods are complex, time-consuming, and yield poor results due to antiquated centrifugation techniques.

Researchers developed an improved method to study Parkinson’s disease in the lab. Along the way, researchers also uncovered clues that may help scientists figure out how to detect Parkinson’s earlier and point the way toward better treatments.

Researchers have questioned whether rare variants associated with IBD, found in people with European ancestry, confer the same risk in African Americans.

Andrew Schulman explores why we need allogeneic therapies, the importance of collaboration to keep the momentum, and challenges and predictions for the future.

The largest and most diverse investigation into prostate cancer genetics yet, which included major increases in representation among men from different racial and ethnic groups, has revealed 187 new risk variants.

Precision treatment for rheumatoid arthritis is key. New research has used a cellular atlas to outline the variety of cellular causes, which may inform targeted, effective therapies.

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer.

A new study has revealed some of the mechanics underlying how breast cancer cells invade healthy tissues. The research, which may offer new drug targets against the spread of cancer cells (metastasis), is published in Advanced Science.

Professor Michael Snyder performed the first longitudinal detailed integrative personal omics profile and used this to assess disease risk and monitor disease states. Technology Networks invited Snyder to an Ask Me Anything session to answer your questions about the future of digital health.